Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

237 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and efficacy of tisagenlecleucel in patients with relapsed or refractory B-cell lymphoma: the first real-world evidence in Japan.
Goto H, Kitawaki T, Fujii N, Kato K, Onishi Y, Fukuhara N, Yamauchi T, Toratani K, Kobayashi H, Yoshida S, Shimo M, Onodera K, Senjo H, Onozawa M, Hirata K, Yokota I, Teshima T. Goto H, et al. Among authors: onozawa m. Int J Clin Oncol. 2023 Jun;28(6):816-826. doi: 10.1007/s10147-023-02334-w. Epub 2023 Apr 18. Int J Clin Oncol. 2023. PMID: 37071252
Hepatitis B virus (HBV) reverse seroconversion (RS) can be prevented even in non-responders to hepatitis B vaccine after allogeneic stem cell transplantation: long-term analysis of intervention in RS with vaccine for patients with previous HBV infection.
Takahata M, Hashino S, Onozawa M, Shigematsu A, Sugita J, Fujimoto K, Endo T, Kondo T, Tanaka J, Imamura M, Teshima T. Takahata M, et al. Among authors: onozawa m. Transpl Infect Dis. 2014 Oct;16(5):797-801. doi: 10.1111/tid.12283. Epub 2014 Aug 25. Transpl Infect Dis. 2014. PMID: 25154638
[Ara-C].
Onozawa M, Teshima T. Onozawa M, et al. Nihon Rinsho. 2015 Feb;73 Suppl 2:623-7. Nihon Rinsho. 2015. PMID: 25831835 Japanese. No abstract available.
Occurrence of adverse events caused by valganciclovir as pre-emptive therapy for cytomegalovirus infection after allogeneic stem cell transplantation is reduced by low-dose administration.
Takahata M, Hashino S, Nishio M, Sugita J, Shigematsu A, Onozawa M, Fujimoto K, Endo T, Kondo T, Tanaka J, Imamura M, Teshima T. Takahata M, et al. Among authors: onozawa m. Transpl Infect Dis. 2015 Dec;17(6):810-5. doi: 10.1111/tid.12456. Epub 2015 Nov 5. Transpl Infect Dis. 2015. PMID: 26354293
Cytogenetically Unrelated Clones in Acute Myeloid Leukemia Showing Different Responses to Chemotherapy.
Kasahara K, Onozawa M, Miyashita N, Yokohata E, Yoshida M, Kanaya M, Kosugi-Kanaya M, Takemura R, Takahashi S, Sugita J, Shigematsu A, Takahata M, Fujisawa S, Hashimoto D, Fujimoto K, Endo T, Kondo T, Teshima T. Kasahara K, et al. Among authors: onozawa m. Case Rep Hematol. 2016;2016:2373902. doi: 10.1155/2016/2373902. Epub 2016 Mar 10. Case Rep Hematol. 2016. PMID: 27034857 Free PMC article.
Reduced-dose methotrexate in combination with tacrolimus was associated with rapid engraftment and recovery from oral mucositis without affecting the incidence of GVHD.
Matsukawa T, Hashimoto D, Sugita J, Nakazawa S, Matsushita T, Kashiwazaki H, Goto H, Onozawa M, Kahata K, Fujimoto K, Endo T, Kondo T, Hashino S, Yamazaki Y, Teshima T. Matsukawa T, et al. Among authors: onozawa m. Int J Hematol. 2016 Jul;104(1):117-24. doi: 10.1007/s12185-016-1996-0. Epub 2016 Apr 27. Int J Hematol. 2016. PMID: 27119977 Free article.
MALDI-TOF MS in post-transplant bloodstream infections: reliable identification of causative bacteria in the neutropenic phase.
Kanaya M, Hayashi Y, Hashimoto D, Endo T, Sugita J, Ohigashi H, Hashiguchi J, Matsukawa T, Matsuoka S, Kosugi-Kanaya M, Goto H, Onozawa M, Kahata K, Fujimoto K, Kondo T, Akizawa K, Shibuya H, Shimizu C, Teshima T. Kanaya M, et al. Among authors: onozawa m. Bone Marrow Transplant. 2017 May;52(5):778-780. doi: 10.1038/bmt.2016.365. Epub 2017 Jan 30. Bone Marrow Transplant. 2017. PMID: 28134922 Clinical Trial. No abstract available.
237 results